Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

CSE/SKNY stock hub

CSE/SKNY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/SKNYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/SKNY

In the news

Latest news · CSE/SKNY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/SKNY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

108

Groups with data

Currency

CAD

Showing 108 of 108 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 14.1M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	CAD 15M
Price	CAD 0.54
Price currency	CAD
Sic	2834
Symbol	cse/SKNY
Website	https://www.lirlifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17.37%
EV Earnings	-5.41x
P/B ratio	14.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	CAD -10,000
Net Income	CAD -2.6M
ROCE	-219.2

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 1.1M
Cash	CAD 920,761
Current Assets	CAD 1M
Current Liabilities	CAD 78,084
Equity	CAD 1.1M
Liabilities	CAD 78,084
Long Term Assets	CAD 101,318
Long Term Liabilities	CAD 0
Net Cash	CAD 920,761
Net Cash By Market Cap	CAD 6.12
Net Debt Equity	CAD -0.87
Tangible Book Value	CAD 962,586
Tangible Book Value Per Share	CAD 0.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.33
Net Working Capital	CAD 41,825
Quick ratio	12.42
Working Capital	CAD 962,586

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-161,625.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.61
All Time High	2.41
All Time High Change	-77.59%
All Time High Date	2026-01-12
All Time Low	0.43
All Time Low Change	25.58%
All Time Low Date	2026-03-20
ATR	0.04
Beta1y	0.78
Ch YTD	-70.49
High	0.57
High52	2.41
High52 Date	2026-01-12
High52ch	-77.59%
Low	0.53
Low52	0.43
Low52 Date	2026-03-20
Low52ch	25.58%
Ma50ch	-10.95%
RSI	47.31
RSI Monthly	0
RSI Weekly	41.04
Sharpe ratio	-0.32x
Sortino ratio	-0.39
Total Return	-161,625.8%
Tr YTD	-70.49
Tr1m	8%
Tr1w	-1.82%
Tr3m	-60.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -2.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,792,881%
Net Borrowing	-168,713
Shares Insiders	7.44%
Shares Out	27,866,957
Shares Qo Q	42.75%
Shares Yo Y	161,625.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	12,945.45x
Bv Per Share	0.04
Ch1m	8
Ch1w	-1.82
Ch3m	-60.58
Ch6m	-55.74
Change	3.85%
Change From Open	0
Close	0.52
Days Gap	3.85
Dollar Volume	11,365.9
Earnings Date	2026-04-15
EBIT	CAD -2.3M
EPS	CAD -0.12
F Score	2
Financing CF	870,304
Fiscal Year End	April
Founded	2,024
Investing CF	1,317,165
Is Primary Listing	1
Last Report Date	2026-01-31
Last Split Date	2025-11-07
Last Split Type	Reverse
Ma20	0.52
Ma20ch	4.05%
Net CF	543,346
Open	0.54
Position In Range	25
Price Date	2026-05-08
Ptbv Ratio	15.63
Relative Volume	1.63x
Share Based Comp	727,050
Tr6m	-55.74%
Volume	21,048

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/SKNY pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns CSE/SKNY?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+7.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+161625.8%

Negative means the company is buying back shares.

Technical

CSE/SKNY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/SKNY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/SKNY stock rating?

cse/SKNY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/SKNY analysis?

The full report lives at /stocks/cse/SKNY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/SKNY?

The latest report frames cse/SKNY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/SKNY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.